"Nafoxidine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An estrogen antagonist that has been used in the treatment of breast cancer.
| Descriptor ID |
D009256
|
| MeSH Number(s) |
D03.383.773.589
|
| Concept/Terms |
U-11,100A- U-11,100A
- U 11,100A
- U11,100A
- U-11000A
- U 11000A
- U11000A
|
Below are MeSH descriptors whose meaning is more general than "Nafoxidine".
Below are MeSH descriptors whose meaning is more specific than "Nafoxidine".
This graph shows the total number of publications written about "Nafoxidine" by people in this website by year, and whether "Nafoxidine" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Nafoxidine" by people in Profiles.
-
Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain. Mol Endocrinol. 1993 Oct; 7(10):1266-74.
-
Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. Cancer Res. 1984 Apr; 44(4):1433-9.
-
Effect of the anti-estrogen, Nafoxidine, on NZB/W autoimmune disease. Arthritis Rheum. 1978 May; 21(4):414-7.
-
Detection of casein messenger RNA in hormone-dependent mammary cancer by molecular hybridisation. Nature. 1977 Sep 01; 269(5623):83-6.
-
Female steroid hormones and lipoprotein synthesis in the cockerel: effects of progesterone and nafoxidine on the estrogenic stimulation of very low density lipoproteins (VLDL) synthesis. Endocrinology. 1977 Jun; 100(6):1636-43.